Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine.

Robbins RJ, Driedger A, Magner J; U.S. and Canadian Thyrogen Compassionate Use Program Investigator Group.

Thyroid. 2006 Nov;16(11):1121-30.

PMID:
17123339
2.

Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH.

Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, Pacini F.

Eur J Endocrinol. 2001 Jan;144(1):5-11.

3.
4.

Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.

Mariani G, Ferdeghini M, Augeri C, Villa G, Taddei GZ, Scopinaro G, Boni G, Bodei L, Rabitti C, Molinari E, Bianchi R.

Cancer Biother Radiopharm. 2000 Apr;15(2):211-7.

PMID:
10803328
5.

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

Luster M, Lippi F, Jarzab B, Perros P, Lassmann M, Reiners C, Pacini F.

Endocr Relat Cancer. 2005 Mar;12(1):49-64. Review.

6.

Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.

Pötzi C, Moameni A, Karanikas G, Preitfellner J, Becherer A, Pirich C, Dudczak R.

Clin Endocrinol (Oxf). 2006 Oct;65(4):519-23.

PMID:
16984246
7.

Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients.

Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1077-86. Epub 2003 May 29.

PMID:
12783219
8.

Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.

Molinaro E, Giani C, Agate L, Biagini A, Pieruzzi L, Bianchi F, Brozzi F, Ceccarelli C, Viola D, Piaggi P, Vitti P, Pacini F, Elisei R.

J Clin Endocrinol Metab. 2013 Jul;98(7):2693-700. doi: 10.1210/jc.2012-4137. Epub 2013 Apr 26.

PMID:
23626005
9.

rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I.

Menzel C, Kranert WT, Döbert N, Diehl M, Fietz T, Hamscho N, Berner U, Grünwald F.

J Nucl Med. 2003 Jul;44(7):1065-8.

11.

Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.

Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C.

J Clin Endocrinol Metab. 2000 Oct;85(10):3640-5.

PMID:
11061516
12.

Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature.

Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM.

Endocr Pract. 2000 Nov-Dec;6(6):460-4. Review.

PMID:
11155220
13.

Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.

Iorcansky S, Herzovich V, Qualey RR, Tuttle RM.

J Clin Endocrinol Metab. 2005 Dec;90(12):6553-5. Epub 2005 Sep 20.

PMID:
16174712
14.

Recombinant human thyrotropin in the management of thyroid cancer.

McDougall IR, Weigel RJ.

Curr Opin Oncol. 2001 Jan;13(1):39-43. Review.

PMID:
11148684
15.

[Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma].

Rajkovaca Z, Kovacević P, Stanetić M, Ristić S.

Vojnosanit Pregl. 2012 Nov;69(11):941-6. Serbian.

PMID:
23311243
16.

Recombinant human TSH in radioiodine treatment of differentiated thyroid cancer.

Kovatcheva RD, Hadjieva TD, Kirilov GG, Lozanov BS.

Nucl Med Rev Cent East Eur. 2004;7(1):13-9.

PMID:
15318305
18.
19.

A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.

Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Graham KE, Braverman LE, Skarulis MC, Davies TF, DeGroot LJ, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Becker DV, Maxon HR 3rd, Cavalieri RR, Spencer CA, McEllin K, Weintraub BD, Ridgway EC.

J Clin Endocrinol Metab. 1999 Nov;84(11):3877-85.

PMID:
10566623
20.

Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.

Luster M, Handkiewicz-Junak D, Grossi A, Zacharin M, Taïeb D, Cruz O, Hitzel A, Casas JA, Mäder U, Dottorini ME; Pediatric rhTSH Investigators Group.

J Clin Endocrinol Metab. 2009 Oct;94(10):3948-53. doi: 10.1210/jc.2009-0593. Epub 2009 Sep 22.

PMID:
19773393

Supplemental Content

Support Center